2invest Past Earnings Performance

Past criteria checks 2/6

2invest's earnings have been declining at an average annual rate of -19%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 70.3% per year. 2invest's return on equity is 8.2%, and it has net margins of 65%.

Key information

-19.0%

Earnings growth rate

-19.0%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate70.3%
Return on equity8.2%
Net Margin65.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

We Think 2invest's (ETR:2INV) Robust Earnings Are Conservative

May 01
We Think 2invest's (ETR:2INV) Robust Earnings Are Conservative

Recent updates

We Think 2invest's (ETR:2INV) Robust Earnings Are Conservative

May 01
We Think 2invest's (ETR:2INV) Robust Earnings Are Conservative

Revenue & Expenses Breakdown

How 2invest makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XTRA:2INV Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 248500
31 Mar 248300
31 Dec 239200
30 Sep 236-300
30 Jun 232-800
31 Mar 233-1500
31 Dec 223-2100
30 Sep 223-2000
30 Jun 223-2000
31 Mar 222-1100
31 Dec 212-200
30 Sep 211-12-10
30 Jun 211-1200
31 Mar 2105600
31 Dec 2005500
30 Sep 20036-20
30 Jun 20036-10
31 Mar 201-440
31 Dec 190-3300
30 Sep 19-7-4-10
30 Jun 19-4-300
31 Mar 19-1-330
31 Dec 181-340
30 Sep 1812-2101
30 Jun 1810-3101
31 Mar 189-391
31 Dec 178-481
30 Sep 176-581
30 Jun 174-561
31 Mar 173-551
31 Dec 162-431
30 Sep 161-331
30 Jun 161-431
31 Mar 161-431
31 Dec 151-431
30 Sep 150-421
30 Jun 150-421
31 Mar 150-321
31 Dec 140-321
30 Sep 140-322
30 Jun 140-322
31 Mar 140-322
31 Dec 130-322

Quality Earnings: 2INV has a large one-off loss of €5.0M impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: 2INV became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2INV has become profitable over the past 5 years, growing earnings by -19% per year.

Accelerating Growth: 2INV has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 2INV has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (-21.2%).


Return on Equity

High ROE: 2INV's Return on Equity (8.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies